FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-26
DOI
10.1038/s41598-018-25263-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fingolimod confers neuroprotection through activation of Rac1 after experimental germinal matrix hemorrhage in rat pups
- (2017) William B. Rolland et al. JOURNAL OF NEUROCHEMISTRY
- FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model
- (2017) Agata Szymiczek et al. Journal of Translational Medicine
- CIP2A expression is elevated in cervical cancer
- (2017) Lisa P. Huang et al. Cancer Biomarkers
- Childhood medulloblastoma
- (2016) Maura Massimino et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer
- (2016) JUAN LI et al. ONCOLOGY REPORTS
- Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival
- (2015) Lauren A. Gillory et al. JOURNAL OF SURGICAL RESEARCH
- Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer
- (2015) Ion Cristóbal et al. Marine Drugs
- Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses
- (2015) Gregory K. Friedman et al. NEURO-ONCOLOGY
- FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells
- (2015) Li Zhang et al. TOXICOLOGY LETTERS
- PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects
- (2015) Raúl Rincón et al. Oncotarget
- Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
- (2014) Jeong-Won Lee et al. INTERNATIONAL JOURNAL OF CANCER
- FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels
- (2014) Limin Chen et al. PLoS One
- FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway
- (2014) Li Zhang et al. TUMOR BIOLOGY
- Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
- (2013) Nicholas G. Gottardo et al. ACTA NEUROPATHOLOGICA
- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system
- (2013) FV Pereira et al. Clinics
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models
- (2012) R. Rosa et al. CLINICAL CANCER RESEARCH
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
- (2012) Sahar A. Saddoughi et al. EMBO Molecular Medicine
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma
- (2012) A. Estrada-Bernal et al. NEURO-ONCOLOGY
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells
- (2011) Craig T. Wallington-Beddoe et al. Autophagy
- Reactivating PP2A by FTY720 as a Novel therapy for AML with C-KIT tyrosine kinase domain mutation
- (2011) Yan Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis
- (2010) Qian-Ze Dong et al. ANNALS OF SURGICAL ONCOLOGY
- FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: A protective role of autophagy
- (2010) Ning Zhang et al. Autophagy
- FTY720 Shows Promising In vitro and In vivo Preclinical Activity by Downmodulating Cyclin D1 and Phospho-Akt in Mantle Cell Lymphoma
- (2010) Q. Liu et al. CLINICAL CANCER RESEARCH
- PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice
- (2010) Tongsen Zheng et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
- (2009) Lisa Diller et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started